Page last updated: 2024-10-24

chlorambucil and Acute Membranous Gingivitis

chlorambucil has been researched along with Acute Membranous Gingivitis in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research Excerpts

ExcerptRelevanceReference
"46 ambulatory patients with chronic lymphocytic leukemia were treated with Prednimustine either continuously (daily or each other day 20 mg) or intermittently (daily 20 mg for 14 days, followed by a pause of 4 weeks)."2.64[Effect of Prednimustine (Leo 1031) in chronic lymphatic leukemia]. ( Böhnel, J; Lutz, D, 1977)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lutz, D1
Böhnel, J1

Trials

1 trial available for chlorambucil and Acute Membranous Gingivitis

ArticleYear
[Effect of Prednimustine (Leo 1031) in chronic lymphatic leukemia].
    Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology, 1977, Volume: 3, Issue:5-6

    Topics: Adult; Aged; Chlorambucil; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Female; Gin

1977